NCT03072914 is a NA clinical trial of RIPC with RIPostC in Moyamoya Disease, sponsored by Seoul National University Hospital.

Who is sponsoring NCT03072914?

NCT03072914 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT03072914?

Interventions in NCT03072914: RIPC with RIPostC.

What condition does NCT03072914 study?

NCT03072914 studies Moyamoya Disease, Remote Ischemic Preconditioning.

Is NCT03072914 still recruiting?

NCT03072914 is currently completed. Last updated 23 August 2018.

Last reviewed 2018-08-23 · How we verify

NCT03072914

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Remote Ischemic Preconditioning With Postconditioning on Neurologic Outcome

Completed NA Last updated 23 August 2018

What this trial tests

NA trial testing RIPC with RIPostC in Moyamoya Disease in 108 participants. Completed in 15 July 2018.

Timeline

7 March 2017

Primary endpoint
15 July 2018

15 July 2018

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	108
Start date	7 March 2017
Primary completion	15 July 2018
Estimated completion	15 July 2018
Sites	1 location across South Korea

Drugs / interventions tested

RIPC with RIPostC

Conditions studied

Moyamoya Disease — all drugs for Moyamoya Disease →
Remote Ischemic Preconditioning — all drugs for Remote Ischemic Preconditioning →

Sponsor

Seoul National University Hospital

Who can join

Adults 18 to 65, any sex, with Moyamoya Disease or Remote Ischemic Preconditioning. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the present study, we evaluated whether RIPC with RIPostC reduce the major neurocomplication in patients undergoing STA-MCA anastomosis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of Combined Remote Ischemic Pre-and Post-Conditioning on Neurologic Complications in Moyamoya Disease Patients Undergoing Superficial Temporal Artery-Middle Cerebral Artery Anastomosis.
Choi ES, Lee YS, Park BS, Kim BG, et al · · 2019 · cited 6× · PMID 31075871 · DOI 10.3390/jcm8050638
Medical Management of Adult Moyamoya Disease: A Review and Relevant Cases With Ischemic Events.
Bang OY, Fujimura M. · · 2025 · cited 2× · PMID 39916450 · DOI 10.5853/jos.2024.04273

Verify or expand the search:

Other recruiting trials for Moyamoya Disease

Currently open trials in the same condition.

NCT07304947 — Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery · NA · recruiting
NCT07140731 — The Symani Restore Study · NA · recruiting
NCT07144930 — Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments · NA · recruiting
NCT07065409 — Treatment of Moyamoya Disease With iPSC-derived Exosomes · Phase 1 · recruiting
NCT06832839 — Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03072914 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 23 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03072914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing